financetom
Business
financetom
/
Business
/
Procter & Gamble's Fiscal Q2 Earnings May Fall Short of Expectations Amid Headwinds, UBS Says
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Procter & Gamble's Fiscal Q2 Earnings May Fall Short of Expectations Amid Headwinds, UBS Says
Jan 17, 2025 12:41 PM

03:20 PM EST, 01/17/2025 (MT Newswires) -- Procter & Gamble's ( PG ) fiscal Q2 earnings may miss consensus estimates, UBS said Friday in a note, adding that a key issue is how the company will approach its full-year guidance taking into account recent headwinds.

For fiscal Q2, UBS analysts said they "believe the bar remains quite low in the wake of the company's commentary around the Blue Yonder disruption in early December," which refers to the supply chain management giant that was hit by a ransomware attack in late November. The analysts also said they believe "the base case is for [fiscal Q2 organic] growth to round down to 2%."

UBS is projecting fiscal Q2 earnings per share of $1.84, below analyst estimates of $1.88 and $1.86 in surveys undertaken by Visible Alpha and FactSet, respectively.

The company is scheduled to release its quarterly results before the opening bell on Jan. 22.

Regarding the company's fiscal year 2025 guidance, UBS analysts said they still "see the low-end as achievable," despite recent headwinds.

UBS has a buy rating on the stock and $189 price target.

Price: 161.06, Change: +0.56, Percent Change: +0.35

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Alnylam Pharmaceuticals Swings to Q3 Non-GAAP Net Loss, Revenue Falls
Alnylam Pharmaceuticals Swings to Q3 Non-GAAP Net Loss, Revenue Falls
Nov 3, 2024
08:37 AM EDT, 10/31/2024 (MT Newswires) -- Alnylam Pharmaceuticals ( ALNY ) reported a Q3 non-GAAP net loss Thursday of $0.50 per diluted share, swinging from non-GAAP net income of $1.74 a year earlier. Analysts polled by Capital IQ expected a loss of $0.39. Revenue for the quarter ended Sept. 30 was $500.9 million, down from $750.5 million a year...
Kellanova's Fiscal Q3 Adjusted Earnings Rise, Net Sales Fall
Kellanova's Fiscal Q3 Adjusted Earnings Rise, Net Sales Fall
Nov 3, 2024
08:33 AM EDT, 10/31/2024 (MT Newswires) -- Kellanova ( K ) reported Q3 adjusted earnings Thursday of $0.91 per diluted share, up from $0.77 a year earlier. Analysts surveyed by Capital IQ expected $0.85. Net sales for the quarter ended Sept. 28 were $3.23 billion, down from $3.26 billion a year earlier. Analysts surveyed by Capital IQ expected $3.15 billion....
TELUS Global Ventures Invests in Two Health Tech Companies
TELUS Global Ventures Invests in Two Health Tech Companies
Nov 3, 2024
08:35 AM EDT, 10/31/2024 (MT Newswires) -- Telus ( TU ) said Thursday that its TELUS Global Ventures is participating in two new funding rounds with equity investments in healthcare tech companies Homethrive and Rhino Health. With the investments, TELUS Global Ventures has now taken stakes in more than 150 companies. Illinois-based Homethrive is focused on providing digital solutions for...
Shell's Solid Q3 Performance: Strong Revenue, $3.5 Billion Buyback, And Refined Capex Guidance
Shell's Solid Q3 Performance: Strong Revenue, $3.5 Billion Buyback, And Refined Capex Guidance
Nov 3, 2024
Shell plc ( SHEL ) shares are trading higher after it reported third-quarter results. Revenue of $71.09 billion beat the consensus of $61.34 billion.  Total production at Integrated Gas fell 4% quarter over quarter (Q/Q) to 941 kboe/d, and Upstream rose 2% Q/Q at 1,811 kboe/d.  Meanwhile, sales volumes at Marketing rose 3% Q/Q to 2,945 thousand b/d, and Refinery processing intake at Chemical & Products declined 9% Q/Q to 1,305...
Copyright 2023-2026 - www.financetom.com All Rights Reserved